SA Spotlight uses AI to summarize content published on Seeking Alpha. All summaries are reviewed by human editors prior to publication. Investors Should Know: Data center operators and real estate ...

BlackRock BLK1.72%increase; up pointing triangle is leading a debt sale targeting at least $12 billion for its massive new El Paso data-center project backed by Meta Platforms META 1.58%increase; up ...

AstraZeneca is pushing its small molecule GLP-1 drug to Phase 3 development for weight control, diabetes and other cardiometabolic conditions despite the asset failing to best one from Structure ...

The hacker behind a breach at education technology giant Instructure claims to have stolen 280 million records tied to students and staff from 8,809 colleges, school districts, and online education ...

Education tech giant Instructure has confirmed a data breach affecting students’ private information. The hacking and extortion gang ShinyHunters claimed responsibility for the breach. The hackers ...

Kirk McKeown, co-founder and CEO of Carbon Arc, breaks down why data, not just AI models, will determine the next wave of innovation in wealth management. As firms race to adopt AI, the real challenge ...

We introduce VeriStruct, a novel framework that extends AI-assisted automated verification from single functions to more complex data structure modules in Verus. VeriStruct employs a planner module to ...

Nvidia has a structured data enablement strategy. Nvidia provides libaries, software and hardware to index and search data faster. The Indexing and retrievals are way faster 10-40X faster in most ...

Abstract: Reconstructing high-frequency seismic data is essential for detailed subsurface imaging and accurate reservoir characterization, particularly when dealing with complex geological formations.

Our data-based ranking is designed to identify and prioritize privacy-relevant methods in Java and JavaScript applications. This ranking process comprises several stages, as depicted in Fig. 3, using ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...